BPO 0.00% 0.3¢ bioprospect limited

sla - sister company bpo related discussion, page-6

  1. 6,187 Posts.
    lightbulb Created with Sketch. 497
    Hi Livas1 I gather it was more about the direction, ie SLA thought resources could have been put into BIO A R&D, and maybe also viewed as a competitor to BIO cosmetic products in some markets. Spat done and dusted IMO - in perspective the R&D cost possibly only relatively the same as say - one director's ongoing remuneration. Overhauled RE-GEN product range to be available locally shortly - ahead of China down the track, tapering marketing costs.
 
watchlist Created with Sketch. Add BPO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.